Gorachand Dutta

Prof. Gorachand Dutta

Indian Institute of Technology Kharagpur (IIT Kharagpur)
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Sensors International
Verified
Journal Article
Open access
RMRiddhipratim Mandal
Riddhipratim Mandal
Gorachand DuttaGorachand Dutta
Gorachand Dutta

23 March 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
NDNirmita Dutta
Nirmita Dutta
PLPeter B. Lillehoj
Peter B. Lillehoj
Pedro EstrelaPedro Estrela
Pedro Estrela
Gorachand DuttaGorachand Dutta
Gorachand Dutta
Cytokines are soluble proteins secreted by immune cells that act as molecular messengers relaying instructions and mediating various functions performed by the cellular counterparts of the immune system, by means of a synchronized cascade of signaling pathways. Aberrant expression of cytokines can be indicative of anomalous behavior of the immunoregulatory system, as seen in various illnesses and conditions, such as cancer, autoimmunity, neurodegeneration and other physiological disorders. Cancer and autoimmune diseases are particularly adept at developing mechanisms to escape and modulate the immune system checkpoints, reflected by an altered cytokine profile. Cytokine profiling can provide valuable information for diagnosing such diseases and monitoring their progression, as well as assessing the efficacy of immunotherapeutic regiments. Toward this goal, there has been immense interest in the development of ultrasensitive quantitative detection techniques for cytokines, which involves technologies from various scientific disciplines, such as immunology, electrochemistry, photometry, nanotechnology and electronics. This review focusses on one aspect of this collective effort: electrochemical biosensors. Among the various types of biosensors available, electrochemical biosensors are one of the most reliable, user-friendly, easy to manufacture, cost-effective and versatile technologies that can yield results within a short period of time, making it extremely promising for routine clinical testing.

9 March 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
Gorachand DuttaGorachand Dutta
Gorachand Dutta
SPSeonhwa Park
Seonhwa Park
ASAmardeep Singh
Amardeep Singh
JSJeongwook Seo
Jeongwook Seo
SKSinyoung Kim
Sinyoung Kim
Haesik YangHaesik Yang
Haesik Yang

23 April 2014 in Analytical Chemistry
Verified
Journal Article
Closed access
Gorachand DuttaGorachand Dutta
Gorachand Dutta
SKSinyoung Kim
Sinyoung Kim
SPSeonhwa Park
Seonhwa Park
Haesik YangHaesik Yang
Haesik Yang

9 August 2017 in The Analyst
Verified
Journal Article
Closed access
PDF file
Gorachand DuttaGorachand Dutta
Gorachand Dutta
PLPeter B. Lillehoj
Peter B. Lillehoj
We report a new enzyme-free electrochemical sensor for ultrasensitive measurements of protein biomarkers in plasma and whole blood samples based on a unique electrochemical–chemical–chemical (ECC) redox cycling signal amplification scheme. This scheme uses methylene blue (MB) as a redox indicator which undergoes an endergonic reaction with Ru(NH3)6 3+ and a highly exergonic reaction with tris(2-carboxyethyl)phosphine (TCEP). This approach offers improved detection sensitivity and sensor stability compared with enzyme-based ECC redox cycling techniques, while involving a simpler sensor modification process and detection protocol. This redox cycling scheme was combined with a robust immunosandwich assay for quantitative measurements of protein biomarkers. For proof of principle, Plasmodium falciparum histidine-rich protein 2 (PfHRP2) was measured in human plasma and whole blood samples, which could be detected down to 10 fg mL−1 and 18 fg mL−1, respectively. Furthermore, this immunosensor exhibits high selectivity, excellent reproducibility and good stability for up to 2 weeks, making it a promising platform for point-of-care testing, especially for detecting extremely low biomarker concentrations in raw biofluids.

1 January 2021 in Sensors International
Verified
Journal Article
Open access
BSBishal Singh
Bishal Singh
BDBrateen Datta
Brateen Datta
DADr. Amlan Ashish
Dr. Amlan Ashish
Gorachand DuttaGorachand Dutta
Gorachand Dutta
Without a doubt, the current global pandemic affects all walks of our life. It affected almost every age group all over the world with a disease named COVID-19, declared as a global pandemic by WHO in early 2020. Due to the high transmission and moderate mortality rate of this virus, it is also regarded as the panic-zone virus. This potentially deadly virus has pointed up the significance of COVID-19 research. Due to the rapid transmission of COVID-19, early detection is very crucial. Presently, there are different conventional techniques are available for coronavirus detection like CT-scan, PCR, Sequencing, CRISPR, ELISA, LFA, LAMP. The urgent need for rapid, accurate, and cost-effective detection and the requirement to cut off shortcomings of traditional detection methods, make scientists realize to advance new technologies. Biosensors are one of the reliable platforms for accurate, early diagnosis. In this article, we have pointed recent diagnosis approaches for COVID-19. The review includes basic virology of SARS-CoV-2 mainly clinical and pathological features. We have also briefly discussed different types of biosensors, their working principles, and current advancement for COVID-19 detection and prevention.